Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 33, 2019 - Issue 20
452
Views
13
CrossRef citations to date
0
Altmetric
Research Articles

Isolation, purification and identification of two new alkaloids metabolites from marine-derived Verrucosispora sp. FIM06025

, , , , , , & show all
Pages 2897-2903 | Received 04 Jun 2018, Accepted 04 Aug 2018, Published online: 16 Nov 2018
 

Abstract

Chemical investigation of a marine-derived actinomycete strain Verrucosispora sp. FIM06025 isolated from a marine sponge sample collected from the East China Sea, resulted in the discovery of two new alkaloids, (2-(hydroxymethyl)-3-(2-(hydroxymethyl)-3-methylaziridin-1-yl) (2-hydroxyphenyl) methanone (1) and 2-(1-hydroxyethyl)-3,4-dihydrobenzo [f] [1,4]oxazepin-5(2H)-one (2). The structures of compounds 1 and 2 were determined by the detailed analysis of 1D, 2D NMR and HR-TOF-MS data, along with literature data analysis. The bioefficacy investigations revealed that compound 1 exhibited a broad spectrum of antimicrobial activity with MIC (minimum inhibitory concentration) values ranging from 3.4 to 200 μg·mL−1 against H. pylori, P. aeroginosa, A. baumanniiin, E. coli and K. pneumonia, S. aureus, C. albicans and E. faecium, however, compound 2, up to 200 μg/mL, displayed no antibacterial activity against these bacteria.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This project was financially supported by the National Key R&D Program of China (2018YFC0311001), Fujian Province Natural Science Foundation (grant number 2015J01290), the Fujian Provincial Major Science and Technology Special Project (grant number 2017R1009-7) and the Fujian Province Marine High-tech Project (grant number Min Marine High-tech [2016]25).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.